Ultragenyx Pharmaceutical | Lucro Por Ação

Preço das Ações
23.39
Mudança Diária
0.35 1.52%
Mensal
-4.30%
Anual
-45.50%
Q1 Previsão
22.67

Fiscal Calendário Atual Consenso Anterior Data
FY2025Q4 Dec/2025 -1.29 -1.17 -1.39 Feb/12 2026
FY2025Q3 Sep/2025 -1.81 -1.23 -1.40 Nov/04 2025
FY2025Q2 Jun/2025 -1.17 -1.29 -1.52 Aug/05 2025
FY2025Q1 Mar/2025 -1.57 -1.53 -2.03 May/06 2025
FY2024Q4 Dec/2024 -1.39 -1.34 -1.52 Feb/13 2025




Eps Alterar Data
Acadia Pharmaceuticals USD 1.6 1.18 2025-12
Agios Pharmaceuticals USD -1.86 0.08 2025-12
Alnylam Pharmaceuticals USD 1.25 1.65 2025-12
BioCryst Pharmaceuticals USD -0.13 0.06 2024-12
BioMarin Pharmaceutical USD 0.46 0.34 2025-12
Esperion Therapeutics USD -0.15 0.18 2024-09
Immunic USD -0.24 0.03 2024-09
Insmed USD -1.54 0.21 2025-12
Ionis Pharmaceuticals USD -1.41 0.61 2025-12
Karyopharm Therapeutics USD -0.15 0.11 2024-12
Kyowa Hakko Kirin JPY 65.79 34.69 2025-12
MacroGenics USD 0.27 0.84 2025-09
Moderna USD -2.11 1.6 2025-12
Neurocrine Biosciences USD 1.88 0.29 2025-12
PTC Therapeutics USD -1.67 1.87 2025-12
Puma Biotechnology USD 0.41 0.5 2024-09
Regeneron Pharmaceuticals USD 11.44 0.39 2025-12
Sarepta Therapeutics USD -3.58 3.45 2025-12
Ultragenyx Pharmaceutical USD -1.29 0.52 2025-12
Vertex Pharmaceuticals USD 5.03 0.23 2025-12
Xoma USD -1.59 2.43 2024-09


Ultragenyx Pharmaceutical Lucro Por Ação - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2026.